Sedation and Acute Encephalopathy in a Pediatric Patient Following Ingestion of Delta-8-Tetrahydrocannabinol Gummies

Peter Akpunonu; Regan A. Baum; Andrew Reckers; Blake Davidson; Ross Ellison; Matthew Riley; Jordan Trecki; Roy Gerona

doi:10.12659/AJCR.933488

11 November 2021 : Case report USA

Sedation and Acute Encephalopathy in a Pediatric Patient Following Ingestion of Delta-8-Tetrahydrocannabinol Gummies

Unusual clinical course, Management of emergency care, Clinical situation which can not be reproduced for ethical reasons

Peter Akpunonu^1ABCDEF*, Regan A. Baum^2ABCDEF, Andrew Reckers^3ABCDEF, Blake Davidson^4ABCDEF, Ross Ellison^3ABCDEF, Matthew Riley^4ABCDEF, Jordan Trecki^5ABCDEF, Roy Gerona^3ABCDEF

DOI: 10.12659/AJCR.933488

Am J Case Rep 2021; 22:e933488

Authors information Article notes Copyright and License information

Background Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Table 1. Laboratory results.

Samples Analyzed for the Drug Enforcement Administration by the UCSF Clinical Toxicology and Environmental Biomonitoring Laboratory (liquid chromatography – quadrupole time-of-flight mass spectrometer)
Sample	Confirmed drug	Concentration (ng/ml)
Serum	Delta-8-THC	107.6
Serum	11-nor-9-carboxy-delta-8-THC	746.5
Urine	11-nor-9-carboxy-delta-8-THC	1550

Back to the Article

Sedation and Acute Encephalopathy in a Pediatric Patient Following Ingestion of Delta-8-Tetrahydrocannabinol Gummies

Your Privacy